Investigator Site 1123 — Wilmington, North Carolina

Investigator Site 1123 is a clinical research site located in Wilmington, North Carolina, United States 28401.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigator Site 1123 has participated in 1 clinical trials.

Therapeutic areas: Acute Coronary Syndrome.

Sponsors: Anthera Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Wilmington

Browse all research sites in North Carolina · View every site in Wilmington

• New Hanover Regional Hospital
• Betty Cameron Women & Children's Hospital
• PMG Research of Wilmington
• Research Site
• GSK Investigational Site
• Trial Management Associates
• New Hanover Regional Medical Center
• Accellacare
• Novant Health New Hanover Regional Medical Center
• Accellacare-Wilmington
• Novo Nordisk Investigational Site
• Wilmington Dermatology Center

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigator Site 1123?

Investigator Site 1123 has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigator Site 1123 conducted?

Investigator Site 1123 has 1 clinical trials on record. Their work covers Acute Coronary Syndrome.

Is Investigator Site 1123 accredited by Crixeo Clinical Trials?

Investigator Site 1123 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigator Site 1123?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.